Literature DB >> 34911515

Assessment of breast cancer risk among Iraqi women in 2019.

Hashim Talib Hashim1, Mustafa Ahmed Ramadhan1, Kabas Monther Theban1, John Bchara2, Ahed El-Abed-El-Rassoul3, Jaffer Shah4.   

Abstract

BACKGROUND: Breast cancer is one of the most common cancers among women worldwide and the leading cause of death among Iraqi women. Breast cancer cases in Iraq were found to have increased from 26.6/100,000 in 2000 to 31.5/100,000 in 2009. The present study aims to assess the established risk factors of breast cancer among Iraqi women and to highlight strategies that can aid in reducing the incidence.
METHODS: 1093 Iraqi females were enrolled in this cross-sectional study by purposive sampling methods. Data collection occurred from July 2019 to September 2019. 1500 women participated in the study, and 407 women were ultimately excluded. The questionnaire was conducted as a self-administrated form in an online survey. Ethical approval was obtained from the College of Medicine in the University of Baghdad. The Gail Model risk was calculated for each woman by the Breast Cancer Risk Assessment Tool (BCRAT), an interactive model developed by Mitchell Gail that was designed to estimate a woman's absolute risk of developing breast cancer in the upcoming five years of her life and in her lifetime.
RESULTS: The ages of the participants ranged from 35 to 84 years old. The mean 5-year risk of breast cancer was found to be 1.3, with 75.3% of women at low risk and 24.7% of women at high risk. The mean lifetime risk of breast cancer was found to be 13.4, with 64.7% of women at low risk, 30.3% at moderate risk, and 5.0% at high risk. The results show that geographically Baghdad presented the highest 5-year risk, followed by Dhi Qar, Maysan, and Nineveh. However, the highest lifetime risk was found in Najaf, followed by Dhi Qar, Baghdad, and Nineveh, successively.
CONCLUSION: Breast cancer is a wide-spreading problem in the world and particularly in Iraq, with Gail Model estimations of high risk in several governorates. Prevention programs need to be implemented and awareness campaigns organized in order to highlight the importance of early detection and treatment.
© 2021. The Author(s).

Entities:  

Keywords:  5 years' risk; Assessment; BCRAT; Breast cancer; Gail Model; Lifetime risk

Mesh:

Year:  2021        PMID: 34911515      PMCID: PMC8672597          DOI: 10.1186/s12905-021-01557-1

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.742


Introduction

Breast cancer is one of the most common cancers among women worldwide, and the second leading cause of death in women after lung cancer [1]. Each year, nearly 2.09 million women are diagnosed with breast cancer and 627 000 die from the disease [2]. In Iraq, breast cancer is the most common cancer, and the leading cause of death among Iraqi women [3]. Breast cancer-related cases in Iraq were found to have increased from 26.6/100,000 in 2000 to 31.5/100,000 in 2009 [4]. Moreover, the age-related incidence rate in Iraq was found to be greater than that in Turkey, Iran, Saudi Arabia, and Bahrain, while less than that in Jordan and Kuwait [5]. Breast cancer risk factors are related to the female’s age, parity, family history of breast cancer, especially first-degree relatives, radiation exposure, smoking, and the genetic factors of BRCA1 and BRCA 2 gene mutations [6]. Awareness of the symptoms and early screening are important methods of reducing the risks associated with breast cancer. The American Cancer Society has developed guidelines for the prevention and early detection of breast cancer, where women with moderate-to-high risks of developing breast cancer are recommended to undergo regular screening mammography tests starting at the age of 45 years [7, 8]. There are many risk assessments models—such as the Gail Model, Claus Model, BRCAPRO Model, and Cuzick–Tyrer Model—that are used as tools to determine a female’s breast cancer-associated risk [9-12]. The Gail Model is the most widely used risk model, as it calculates both a 5-year risk and a lifetime risk of breast cancer. This risk is measured based on the woman’s age, age of menarche, age of first birth, family history, and number of biopsies conducted [11, 13]. The Gail Model has been validated in many countries and is used extensively in many studies as a tool to assess breast cancer-related risk [13]. This study aims to assess the established risk factors of breast cancer among Iraqi women and to highlight the benefits of certain strategies that can aid in controlling its incidence.

Materials and methods

The aim, design and setting of the study

Our study is a cross-sectional study, enrolling 1093 Iraqi females, out of an estimated population of 41 million, by purposive sampling methods from all of Iraq’s 18 governorates [14].

The characteristics of participants or description of materials

The purpose of this study was explained to each participant before acquiring their consent to participate, and those who refused to participate were excluded. Women who had previously received chest radiation therapy for the treatment of Hodgkin Lymphoma were also excluded. Data collection occurred from July 2019 to September 2019, with 1500 women participating in the study from all of Iraq’s cities. 407 women were excluded for the following reasons: 150 refused to participate, 169 had already been diagnosed with breast cancer, and 88 had received chest radiation for the treatment of Hodgkin Lymphoma. As a result, only 1093 women were included the study. The Gail Model was implemented to assess the risk of breast cancer among the study records. This model is known by the National Cancer Institute as BCRAT (Breast Cancer Risk Assessment Tool). The questionnaire was conducted as a self-administrated form in an online survey, as well as face-to-face interviewing and a paper survey. A pilot study of 73 participants was first performed in order to test the validity and reliability of the Arabic version of the questionnaire. It was tested for validity by sending a translation of the questionnaire to six experts in the specialty—three from Baghdad Medical College, two from Dhi Qar Medical College, and one from Basra Medical College—that all accepted the format upon revision. The questionnaire was further tested for reliability by assessing the 5-year risk of the first 73 women upon administering the survey, and then repeating the survey with the same group at a later point of time to compare the predicted risk for each. The overall internal reliability (Cronbach’s α = 0.87) was high. A structured questionnaire was used to collect sociodemographic data from participants, including number of children, occupation, educational level, monthly income, use of contraceptives, breast feeding, smoking, and physical activity. In addition, details were collected regarding risk factors for breast cancer, such as age, age at menarche, age at the 1st live birth, number of previous breast biopsies, presence of atypical hyperplasia in any previous breast biopsy specimen, and history of breast cancer among the participant’s first-degree relatives (mother, daughter and sister). Participant race was also collected on the questionnaire, with three options relating to the three main races of Iraqi women (Arabic, Kurdish, and Turkmen). Ethical approval was obtained from the College of Medicine in the University of Baghdad in order to conduct the study.

The statistical analysis

A Student’s t-test was used to check for any significant differences between the mean values of two continuous variables. Multiple linear regression models were also used to estimate the effect of each variable on the 5-year and lifetime breast cancer risk. The level P < 0.05 was considered as the cutoff value for significance. The Gail Model risk for each woman was calculated by Breast Cancer Risk Assessment Tool (BCRAT), an interactive model developed by Mitchell Gail for estimating a woman’s absolute risk of developing invasive breast cancer in both the upcoming five years of her life and her entire lifetime. The Gail Model calculates the probability of a woman at age α who has age-related relative risk r(t). The woman may develop breast cancer by age α + τ according to the following equation:where () is the baseline age–specific hazard of developing breast cancer and is the probability of surviving competing risks up to age t [15]. The baseline age–specific hazard rates were obtained from the average (“composite”) age–specific breast cancer rates () using () = ()(), where () is 1 minus the attributable risk fraction for age t [16]. Statistical Package for the Social Science (SPSS) version 25 and Statistical Analysis Software (SAS) version 16 were used in calculations and significance testing. Using the Gail Model as a golden standard, a woman with a probability of less than 1.66% of developing breast cancer in 5 years is considered to be at low risk. Conversely, a woman with a probability of more than 1.66% is classified as high risk and is recommended to undergo intensive screening by annual mammography and clinical breast examination every 6 to 12 months [15]. Regarding lifetime risk, a woman with a probability of less than 15% of developing breast cancer is considered to be at low risk, a woman with a probability of 15–30% is considered to be at moderate risk, and a woman with a probability of more than 30% is considered to be at high risk. Lifetime risk is defined as the risk of developing breast cancer up to 90 years of age [15].

Results

The ages of the participants ranged from 35 to 84 years old, with a mean of 46.4 and a standard deviation of 9.5. The characteristics of the study participants are further clarified in Table 1.
Table 1

Characteristics of study participants

FrequencyPercentage
1. Are your parents blood relatives?
Yes47343.3
No61456.2
Unknown60.5
2. Marital status
Yes100692
No878
3. Educational level
Illiterate21119.3
Primary25223.1
Secondary29326.8
University33730.8
4. Number of children
No children13112
1–2 children16214.8
3–5 children47643.5
More than 532429.6
5. Age at first live birth
No birth13011.9
Less than 20 years34631.7
20–24 years35132.1
25–29 years19517.8
30–39 years696.3
More than 40 years20.2
6. Breast feeding
Yes84677.4
No24722.6
7. Use of contraceptives
Yes54449.8
No54950.2
8. Age of menarche (first menstrual cycle)
7–11 years11310.3
12–13 years67161.4
More than 13 years30928.3
9. Premenopausal of postmenopausal
Premenopausal74167.8
Postmenopausal35232.2
10. Race
Arabic88180.6
Kurdish13712.5
Turkmen756.9
11. Monthly income to family
Low (Less than 250 IQD)22420.5
Moderate (250–Million IQD)61556.3
High (More than Million IQD)25423.2
12. Smoking (including shisha and vape)
Yes575.2
No103694.8
13. Physical activity
Never64859.3
Once weekly18817.2
Twice weekly11610.6
More than twice weekly14112.9
14. Number of biopsies
No Biopsy105896.8
One Biopsy (Without Hyperplasia)353.2
15. Number of first-degree relatives with breast cancer
No one90783
One relative12011
More than one relative666
16. Occupation
Housewife73667.3
Others35732.7
Characteristics of study participants Table 2 shows the distribution of the participants throughout the Iraqi governorates.
Table 2

The governorates of the participants

FrequencyPercentage
Anbar464.2
Babil454.1
Baghdad19117.5
Basra978.9
Dhi Qar756.9
Diyala474.3
Dohuk444
Erbil534.8
Karbala333
Kirkuk585.3
Maysan524.8
Muthanna403.7
Najaf625.7
Nineveh605.5
Qadisiyyah534.8
Saladin514.7
Sulaymaniyah373.4
Wasit494.5
Total1093100
The governorates of the participants The mean of the 5-year risk was found to be 1.3 with a standard deviation of 1.0, and the mean of the lifetime risk was 13.4 with a standard deviation of 6.8. Table 3 lists the frequencies of the risks among the participants.
Table 3

The 5–year risk frequencies

FrequencyPercentage
Low82375.3
High27024.7
Total1093100
The lifetime risk frequencies
Low70764.7
Moderate33130.3
High555.0
Total1093100.0
The 5–year risk frequencies Table 4 shows the 5-year risk and the lifetime risk assessment measured using the Gail Model for the characteristics of study participants.
Table 4

Risk assessment using the Gail model

5-year riskLifetime risk
LowHighLowModerateHigh
1. Are your parents blood relatives?
Yes364 (44.2%)109 (40.3%)295 (41.7%)151 (45.7%)27 (49%)
No455 (55.2%)159 (59%)409 (57.8%)177 (53.4%)28 (51%)
Unknown4 (0.6%)2 (0.7%)3 (0.5%)3 (0.9%)(0%)
2. Marital status
Yes741 (90%)265 (98%)625 (88.4%)327 (98.8%)54 (98.2%)
No82 (10%)5 (2%)82 (11.6%)4 (1.2%)(1.8%)
3. Educational level
Illiterate114 (13.8%)97 (36%)131 (18.5%)73 (22%)7 (12.8%)
Primary191 (23.2%)61 (22.6%)127 (18%)113 (34.1%)12 (21.8)
Secondary238 (29%)55 (20.3%)177 (25%)98 (29.6%)18 (32.7%)
University280 (34%)57 (21.1%)272 (38.5%)47 (14.3%)(32.7%)
4. Number of children
No children129 (15.6%)2 (0.7%)130 (18.3%)1 (0.3%)0 (0%)
1–2 children127 (15.4%)35 (13%)98 (13.8%)55 (16.6%)9 (16.3%)
3–5 children375 (45.5%)101 (37.4%)303 (42.8%)141 (42.5%)32 (58.1%)
More than 5192 (23.5%)132 (48.9%)176 (25.1%)134 (40.6%)(25.6%)
5. Age at first live birth
No birth128 (15.6%)2 (0.7%)129 (18.2%)1 (0.3%)0 (0%)
Less than 20 years181 (22%)165 (61%)70 (10%)255 (77%)21 (38.3%)
20–24 years296 (36%)55 (20.3%)283 (40%)43 (13%)25 (45.4%)
25–29 years169 (20.5%)26 (9.6%)169 (24%)18 (5.4%)8 (14.5%)
30–39 years47 (5.7%)22 (8.4%)54 (7.6%)14 (4.3%)1 (1.8%)
More than 40 years2 (0.2%)0 (0%)2 (0.2%)0 (0%)(0%)
6. Breast feeding
Yes617 (75%)229 (84.8%)515 (72.9%)289 (87.4%)42 (76.4%)
No206 (25%)41 (15.2%)192 (27.1%)42 (12.6%)(23.6%)
7. Use of contraceptives
Yes424 (52.6%)120 (44.4%)314 (44.4%)201 (60.7%)29 (52.8%)
No399 (48.4%)150 (55.6%)393 (55.6%)130 (39.3%)(47.2%)
8. Age of menarche (first menstrual cycle)
7–11 years63 (7.7%)50 (18.2%)52 (7.3%)47 (14.1%)14 (25.6%)
12–13 years496 (60.2%)175 (64.8%)417 (59%)219 (66.1%)35 (63.4%)
More than 13 years264 (32.1%)45 (17%)238 (33.7%)65 (19.8%)(11%)
9. Premenopausal of postmenopausal
Premenopausal179 (21.7%)173 (21%)445 (63%)256 (77.4%)40 (72.8%)
Postmenopausal644 (78.3%)97 (79%)262 (37%)75 (22.6%)(27.2%)
10. Race
Arabic665 (80.8%)216 (80%)564 (79.7%)271 (82%)46 (83.6%)
Kurdish99 (12%)38 (14%)89 (12.5%)42 (12.6%)6 (11%)
Turkmen59 (7.2%)16 (6%)54 (7.8%)18 (5.4%)(5.4%)
11. Monthly income to family
Low (Less than 250 IQD)164 (20%)60 (22%)130 (18.5%)81 (24.5%)13 (23.8%)
Moderate (250–Million IQD)459 (55.7%)156 (58%)385 (54.4%)198 (59.8%)32 (58.1%)
High (More than Million IQD)200 (24.3%)54 (20%)192 (27.1%)52 (15.7%)(18.1%)
12. Smoking (including shisha and vape)
Yes32 (4%)25 (9%)40 (5.7%)12 (3.7%)5 (9%)
No791 (96%)245 (91%)667 (94.3%)319 (96.3%)(91%)
13. Physical activity
Never473 (57.4%)175 (65%)421 (59.5%)201 (60.7%)26 (47.2%)
Once weekly146 (17.7%)42 (16%)120 (17%)58 (17.5%)10 (18.1%)
Twice weekly85 (10.4%)31 (11%)80 (11.3%)25 (7.5%)11 (20.2%)
More than twice weekly119 (14.5%)22 (8%)86 (12.2%)47 (14.3%)(14.5%)
14. Number of biopsies
No biopsy804 (97.7%)254 (94%)16 (2.3%)13 (4%)6 (11%)
One biopsy (Without hyperplasia)19 (2.3%)16 (6%)691 (97.7%)318 (96%)(39%)
15. Number of first-degree relatives with breast cancer
No one745 (90.5%)162 (60%)670 (94.7%)235 (71%)2 (3.7%)
One relative68 (8.25%)52 (19.25%)31 (4.3%)88 (26.5)1 (1.8%)
More than one relative10 (1.25%)56 (20.75%)6 (1%)8 (2.5%)52 (94.5%)
Risk assessment using the Gail model Table 5 shows the general linear regression model analysis predictors for both the 5–year and lifetime risks of developing breast cancer in Iraqi women between 35 and 85 years of age. The identified predictors for breast cancer in women were listed as age, age at menarche, age of first birth, number of first-degree relatives with breast cancer, race, number of biopsies, age of menopause, contraceptives usage, monthly income, smoking, and physical activity. Variables with (P < 0.001) were considered significant and strong predictors for breast cancer.
Table 5

Linear regression results for the 5-year and lifetime risks

R-valueR2-value (%)Standard errorP value
5-year risk
Age0.61537.80.8156< 0.001
Age of menarche0.235.31.0065< 0.001
Age at first birth0.0270.11.033870.369
Number of biopsies0.1241.51.02626< 0.001
Race0.01301.034170.676
First degree relatives0.54629.80.8666< 0.001
Menopause0.45921.10.9189< 0.001
Using of contraceptives0.0440.21.0332530.145
Monthly income0.0250.11.033930.406
Smoking0.1582.51.0212310
Physical activity0.0550.31.0327020.07
Lifetime risk
Age0.33611.36.45360
Age of menarche0.2024.16.70980.003
Age at first birth0.1773.16.74270.01
Number of biopsies0.00206.8514210.978
Race0.0470.26.843760.497
First degree relatives0.75356.84.505560
Menopause0.2807.86.577070
Using of contraceptives0.0650.46.837040.353
Monthly income0.0810.76.8289120.245
Smoking0.0790.66.8299240.256
Physical activity0.0670.46.8360880.337
Linear regression results for the 5-year and lifetime risks Globally reported Gail’s breast cancer risk assessments are classified in Table 6. The Gail Model overestimates risk in most of the studies outside the United States, due to the fact that the risk factors and incidence rates of breast cancer vary greatly across different races and countries.
Table 6

Gail's breast cancer risk in various countries

CountryYearSample sizeAge5–year riskLifetime risk
USA [13]19894496> 501.0211.21
USA [17]2001319≥ 351.67
USA [18]2004254> 401.58.4
USA [19]20058388> 180.88
USA [20]200699≥ 354.1323.5
USA [21]2009883> 400.88
USA [22]2016124> 501.67
Iraq (Baghdad) [23]2016250≥ 350.9511.3
Iraq (This Study)20191093≥ 351.3313.36
Iran [24]20082000≥ 350.929.14
Iran [25]2012314≥ 350.89
Iran [26]2016560≥ 350.68.9
Iran [27]20163847≥ 351.6111.71
Turkey [28]2010650≥ 351.677.7
Turkey [29]2011415> 201.715
Turkey [15]2015231≥ 350.889.37
United Kingdom [15]2013355> 461.59
Bulgaria [31]2009315≥ 351.51
India [32]2013200≥ 357.8
Korea [33]20133789< 500.442.24
Czech Republic [34]20064598≥ 351.378.02
Qatar [24]20161488≥ 351.1210.57
Saudi Arabia [35]2017180≥ 350.879.6
Bahrain [36]2013300≥ 350.79.3
Gail's breast cancer risk in various countries Figure 1 shows the distribution of both risks on the governorates. It shows that Baghdad presents the highest 5-year risk, followed by Dhi Qar, Maysan, and Nineveh, in that order. Najaf presents the highest lifetime risk, followed by Dhi Qar, Baghdad, and Nineveh successively.
Fig. 1

5-year and lifetime risk distribution among the governorates

5-year and lifetime risk distribution among the governorates

Discussion

We found that the 5-year risk and lifetime risk of developing breast cancer for women in Iraq is 1.3 and 13.4, respectively. These figures are higher than those of a previous study performed in 2016 in Baghdad, which found a 5-year risk and lifetime risk of 0.95 and 11.3, respectively [23]. (For Baghdad only, we found 5-year and lifetime risk of 1.3 and 11.2, respectively, indicating that the 5-year risk increased but the lifetime risk stayed the same for the city). Baghdad, Dhi Qar, Maysan, and Nineveh have the highest 5-year risk, while Najaf, Dhi Qar, Baghdad, and Nineveh have the highest lifetime risk. Dhi Qar has a very high risk in both cases, so screening programs are especially important in this governorate; however, preventative measures should also be implemented in all. According to the linear regression model, we found that age, family history, and menopause are the most important predictors for 5-year risk (with smoking playing a role as well), while family history is the most important predictor for lifetime risk. Comparing data from studies performed in other countries (Table 6), Iraq has the highest breast cancer risk. Prevention programs are therefore essential to eliminate high risk among Iraqi women, especially when one considers that breast cancer rates are increasing greatly throughout Iraq. According to the Gail Model, older women have a greater risk of breast cancer—as age increases, the risk of BC increases. We found this to be true in our results, as risk was highest among the older age groups. This trend is similar to that of nearby countries, as shown in Table 6. We found that Iraq has the greatest risk of breast cancer among all countries, which may be due to the sociopolitical circumstances of the country (chemical warfare, bombings, etc.). This is likely why we see higher BC risk in the southern governorates such as Basra and Thi Qar, since these regions have historically been more prone to wars than the others (particularly in 1991 and 2003, when the wars were at their peak). Women who take contraceptive pills should be aware of the fact that they are predisposed to breast cancer, according to the Gail Model and based on the results of our study. In addition, our study corrobated the association from previous studies that found women who do not breast feed their children are at a higher risk for BC. We found women with a family history of breast cancer are at increased risk of developing breast cancer compared to women with no family history of breast cancer and recommend these women perform regular checks on themselves as a preventative measure. Moreover, there was no statistical difference in the effect of age on the demographic and clinical profiles of breast cancer among premenopausal versus postmenopausal Iraqi patients after controlling for marital status, level of education, and number of parities. In Iraq, a significant proportion of breast cancer patients have a locally advanced disease at the time of diagnosis. To reinforce our national early detection program, it is essential to encourage public awareness through educational campaigns. Screening programs and educational campaigns that teach Iraqi women to check their breasts regularly are crucial to limit this type of cancer. Considering that Iraq has a poor healthcare system and that many patients are deprived of high-quality care, it is imperative that preventative measures be discussed in order to reduce the incidence of breast cancer in the population [30].

Limitations

It is worth mentioning the limitations that were observed while conducting this study. Chiefly, the Gail Model is calibrated to the United States’ population of women, and due to many variables, risk calculations might not be consistent for Iraqi women. Moreover, problems were encountered with sample randomization, since some women refused to participate, and some others had already been diagnosed with breast cancer.

Conclusion

Breast cancer is a wide-spreading problem in the world and particularly in Iraq. The Gail Model estimates the risk of developing breast cancer in any population, depending on its variables. The 5–year risk of BC among Iraqi women in 2019 was found to be distributed chiefly between Baghdad, Dhi Qar, Nineveh, and Maysan, with the greatest lifetime risk in Najaf and Dhi Qar. Screening programs are considered essential and heavily recommended in the process of breast cancer control and prevention. Prevention programs need to be implemented and awareness campaigns organized in order to highlight the importance of early detection and treatment to improve survival.
  28 in total

Review 1.  Assessing the risk of breast cancer.

Authors:  K Armstrong; A Eisen; B Weber
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

2.  [Is the Gail model for breast cancer risk assessment valid for the Bulgarian women?].

Authors:  G Baitchev; P Christova; I Ivanov
Journal:  Khirurgiia (Sofiia)       Date:  2009

3.  American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.

Authors:  Debbie Saslow; Carla Boetes; Wylie Burke; Steven Harms; Martin O Leach; Constance D Lehman; Elizabeth Morris; Etta Pisano; Mitchell Schnall; Stephen Sener; Robert A Smith; Ellen Warner; Martin Yaffe; Kimberly S Andrews; Christy A Russell
Journal:  CA Cancer J Clin       Date:  2007 Mar-Apr       Impact factor: 508.702

4.  Comparisons of two breast cancer risk estimates in women with a family history of breast cancer.

Authors:  A McTiernan; A Kuniyuki; Y Yasui; D Bowen; W Burke; J B Culver; R Anderson; S Durfy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-04       Impact factor: 4.254

5.  Risk of breast cancer, health beliefs and screening behaviour among Turkish academic women and housewives.

Authors:  Meryem Yilmaz; Gungor Guler; Mine Bekar; Nuran Guler
Journal:  Asian Pac J Cancer Prev       Date:  2011

6.  Breast cancer risk assessment in the Czech female population--an adjustment of the original Gail model.

Authors:  Jan Novotny; Ladislav Pecen; Lubos Petruzelka; Adam Svobodnik; Ladislav Dusek; Jan Danes; Miloslava Skovajsova
Journal:  Breast Cancer Res Treat       Date:  2005-12-01       Impact factor: 4.872

7.  Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.

Authors:  Kevin C Oeffinger; Elizabeth T H Fontham; Ruth Etzioni; Abbe Herzig; James S Michaelson; Ya-Chen Tina Shih; Louise C Walter; Timothy R Church; Christopher R Flowers; Samuel J LaMonte; Andrew M D Wolf; Carol DeSantis; Joannie Lortet-Tieulent; Kimberly Andrews; Deana Manassaram-Baptiste; Debbie Saslow; Robert A Smith; Otis W Brawley; Richard Wender
Journal:  JAMA       Date:  2015-10-20       Impact factor: 56.272

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Assessment of the clinical utility of the Gail model in estimating the risk of breast cancer in women from the Indian population.

Authors:  Vasu Reddy Challa; Krishnamurthy Swamyvelu; Naren Shetty
Journal:  Ecancermedicalscience       Date:  2013-10-17

10.  Prevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study.

Authors:  Waseem Khaliq; Danijela Jelovac; Scott M Wright
Journal:  BMJ Open       Date:  2016-11-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.